慢性脑功能衰竭的药物治疗评估
Assessment of drug therapy in chronic brain failure.
作者信息
Lloyd-Evans S, Brocklehurst J C, Palmer M K
出版信息
Gerontology. 1978;24(4):304-11. doi: 10.1159/000212264.
An 'arteriosclerosis score' has been devised in an attempt to differentiate between vascular and ideopathic chronic brain failure. The score was found to correlate closely with the ADL score, but not with MSQ score, nor with a battery of seven psychological tests. There are, however, close intercorrelations between certain psychological tests and the MSQ. This paper describes a series of tests, their correlations with each other in a group of elderly people, difficulties in their administration and the practical problems inherent in assessing drugs intended to be used in the prevention or treatment of brain failure.
为了区分血管性和特发性慢性脑衰竭，已经设计出了一种“动脉硬化评分”。结果发现，该评分与日常生活活动能力（ADL）评分密切相关，但与简易精神状态检查表（MSQ）评分无关，也与一组七项心理测试无关。然而，某些心理测试与MSQ之间存在密切的相互关联。本文描述了一系列测试、它们在一组老年人中的相互关系、测试实施中的困难以及评估用于预防或治疗脑衰竭药物时所固有的实际问题。
Zotero 插件